Incidence, Risk Factors, and Outcome of Cytomegalovirus Infection and Disease in Patients Receiving Prophylaxis with Oral Valganciclovir or Intravenous Ganciclovir after Umbilical Cord Blood Transplantation Pau Montesinos, Jaime Sanz, Susana Cantero, Ignacio Lorenzo, Guillermo Martín, Silvana Saavedra, Javier Palau, Mónica Romero, Alberto Montava, Leonor Senent, Jesús Martínez, Isidro Jarque, Miguel Salavert, Juan Córdoba, Lola Gómez, Shirley Weiss, Federico Moscardó, Javier de la Rubia, Luis Larrea, Miguel A. Sanz, Guillermo F. Sanz Biology of Blood and Marrow Transplantation Volume 15, Issue 6, Pages 730-740 (June 2009) DOI: 10.1016/j.bbmt.2009.03.002 Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 1 Cumulative incidence curves of CMV infection after UCBT. (A) CI in CMV-seropositive patients according to CMV prophylaxis. (B) CI according to the recipient CMV serostatus. Biology of Blood and Marrow Transplantation 2009 15, 730-740DOI: (10.1016/j.bbmt.2009.03.002) Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 2 Cumulative incidence curves of infection-related mortality after UCBT. (A) CI in CMV-seropositive patients according to CMV prophylaxis. (B) CI according to the recipient CMV serostatus. Biology of Blood and Marrow Transplantation 2009 15, 730-740DOI: (10.1016/j.bbmt.2009.03.002) Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions